ArticleAnnals of translational medicine2021

miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1.

Wenliang Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.